ARCTURUS THERAPEUTICS INC.

In News

Arcturus Therapeutics Holdings Inc (ARCT) Q3 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Business Wire

Business Wire - Nov 10, 2025

Arcturus' stock halves after mRNA therapy fails to evoke efficacy in cystic fibrosis trial - Fierce Biotech

Fierce Biotech - Oct 22, 2025

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress - BioSpace

BioSpace - Aug 12, 2025

Citigroup Maintains Arcturus Therapeutics Holdings (ARCT) Neutral Recommendation - Nasdaq

Nasdaq - Nov 13, 2025

Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating - Seeking Alpha

Seeking Alpha - Sep 23, 2025

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm - PR Newswire

PR Newswire - Nov 10, 2025

Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire

Business Wire - Nov 24, 2025

Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Yahoo Finance - Nov 10, 2025

Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug - BioSpace

BioSpace - Oct 23, 2025

How Recent Shifts Are Rewriting the Story for Arcturus Therapeutics Holdings - Yahoo Finance

Yahoo Finance - Oct 22, 2025

Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program - Yahoo Finance

Yahoo Finance - Oct 22, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment